The latest closing stock price for TransCode Therapeutics as of June 20, 2025 is 7.57.
An investor who bought $1,000 worth of TransCode Therapeutics stock at the IPO in 2021 would have $-1,000 today, roughly -1 times their original investment - a -94.75% compound annual growth rate over 4 years.
The all-time high TransCode Therapeutics stock closing price was 1000000.00 on July 09, 2021.
The TransCode Therapeutics 52-week high stock price is 1035.40, which is 13577.7% above the current share price.
The TransCode Therapeutics 52-week low stock price is 6.15, which is 18.8% below the current share price.
The average TransCode Therapeutics stock price for the last 52 weeks is 251.04.
An investor who bought $1,000 worth of TransCode Therapeutics stock at the IPO in 2021 would have $-1,000 today, roughly -1 times their original investment - a -94.75% compound annual growth rate over 4 years.
The all-time high TransCode Therapeutics stock closing price was 1000000.00 on July 09, 2021.
The TransCode Therapeutics 52-week high stock price is 1035.40, which is 13577.7% above the current share price.
The TransCode Therapeutics 52-week low stock price is 6.15, which is 18.8% below the current share price.
The average TransCode Therapeutics stock price for the last 52 weeks is 251.04.